P4NP7S
A fragment of the 7S domain of type IV collagen, enabling non-invasive monitoring of basement membrane formation and extracellular matrix remodeling in fibrotic diseases.
Key features and values
- Quantifies type IV collagen fragments indicative of basement membrane formation.
- Reflects extracellular matrix remodeling associated with fibrotic diseases.
- Provides a non-invasive measure of basement membrane dynamics.
- Supports monitoring of disease progression and response to therapies targeting fibrosis.
- Applicable in research on diseases characterized by aberrant extracellular matrix turnover.
- Facilitates evaluation of interventions aimed at modulating extracellular matrix formation.
- Complements other biomarkers for a comprehensive assessment of tissue remodeling dynamics.
Description
The P4NP7S biomarker assay measures specific fragments of the 7S domain of type IV collagen, serving as an indicator of basement membrane formation and extracellular matrix remodeling. This non-invasive assay provides insights into tissue remodeling processes associated with fibrotic diseases. By quantifying type IV collagen degradation products, the P4NP7S assay aids in monitoring disease progression, evaluating treatment efficacy, and understanding the underlying mechanisms of tissue fibrosis and damage. It serves as a valuable tool in research settings for assessing the dynamics of extracellular matrix turnover and fibrotic tissue remodeling.
Nordic Bioscience’s assays and services are research use only products and services and do not qualify for medical or diagnostic purposes.
